お知らせ :東京証券取引所JASDAQスタンダード市場への新規上場に関するお知らせ

株式会社グローバルインフォメーション
表紙
市場調査レポート
商品コード
928406

中国の整形外科バイオマテリアル市場(2020年~2026年): MedSuite

Orthopedic Biomaterials Market Report Suite | China | 2020-2026 | Medsuite

出版日: | 発行: iData Research Inc. | ページ情報: 英文 131 Pages | 納期: 即日から翌営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=104.84円

※ Single Userライセンスは、DRM (デジタル著作権管理システム) 付PDFになります。
認証されたPC上のみでの閲覧となっております。

中国の整形外科バイオマテリアル市場(2020年~2026年): MedSuite
出版日: 2020年03月01日
発行: iData Research Inc.
ページ情報: 英文 131 Pages
納期: 即日から翌営業日
担当者のコメント
当サービス(MedSuite)は、セグメント別(MedCore)にご注文可能です。(USD3,995/1セグメント)。まずはサンプル送付させていただきますので、ご希望のセグメントをお知らせください。セグメント: 「骨移植代替物市場」「整形外科用成長因子市場」「ヒアルロン酸関節内補充薬市場」
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

当レポートでは、中国における整形外科用バイオマテリアル市場について調査し、市場の動向、手術件数、各製品セグメント市場における概況・成長促進要因・成長抑制要因・競合状況など、体系的な情報を提供しています。

目次

図表

エグゼクティブサマリー

  • 中国における整形外科用バイオマテリアル市場の市場概要
  • 競合分析
  • 市場動向
  • 主な市場開発
  • 対象手術
  • 対象市場
  • 主要レポートのアップデート
  • バージョン履歴

欧州のニューロモデュレーション、神経血管および神経外科デバイス市場の概要

競合分析

市場動向

市場開発

対象手術

対象市場

主要レポートのアップデート

バージョン履歴

調査方法

  • 調査範囲
  • IDATAによる9段階の調査手法
  • ステップ1:プロジェクトの開始とチームの選定
  • ステップ2:データシステムの準備および2次調査の実施
  • ステップ3:インタビューの準備およびアンケートの設計
  • ステップ4: 1次調査の実施
  • ステップ5: 調査分析 - ベースライン推計の確立
  • ステップ6:市場予測および分析
  • ステップ7:戦略的機会の特定
  • ステップ8:最終レビューおよび市場リリース
  • ステップ9:顧客フィードバックおよび市場モニタリング

中国における整形外科生体材料市場の市場概要

  • イントロダクション
    • 骨移植代替物
    • ヒアルロン酸関節内補充薬
    • 成長因子
  • 為替レート
  • 市場概要
  • 動向分析
  • 市場成長促進要因・抑制要因
    • 促進要因
    • 抑制要因
  • 競合分析
  • 合併と買収

処置件数

  • 骨移植片代替物の処置件数
    • マテリアル別
    • 適応症別
  • ヒアルロン酸関節内補充薬の処置件数
    • 注射サイクル別
  • 整形外科用成長因子の処置件数
    • 処置件数

骨移植代替物市場

  • イントロダクション
  • 市場概要
    • マテリアル別
    • 適応症別
  • 市場分析・予測
    • 市場全体
    • マテリアル別
    • 適応症別
  • 成長促進要因・抑制要因
    • 促進要因
    • 抑制要因
  • 競合分析

ヒアルロン酸関節内補充薬市場

  • イントロダクション
  • 市場概要
    • 注射サイクル別
  • 市場分析・予測
    • 市場全体
    • 注射サイクル別
  • 成長促進要因・抑制要因
    • 促進要因
    • 抑制要因
  • 競合分析

整形外科用成長因子市場

  • イントロダクション
  • 市場分析・予測
    • 整形外科用成長因子市場
  • 成長促進要因・抑制要因
    • 促進要因
    • 抑制要因
  • 競合分析

付録:国内競合企業ディレクトリ

略語

図表

LIST OF CHARTS

  • Chart 1 1: Orthopedic Biomaterials Market by Segment, China, 2012 - 2022
  • Chart 1 2: Orthopedic Biomaterials Market Overview, China, 2015 & 2022
  • Chart 3 1: Orthopedic Biomaterials Market by Segment, China, 2012 - 2022
  • Chart 3 2: Orthopedic Biomaterials Market Breakdown, China, 2015
  • Chart 3 3: Orthopedic Biomaterials Market Breakdown, China, 2022
  • Chart 3 4: Growth Rates by Segment, Orthopedic Biomaterials Market, China, 2012 - 2022
  • Chart 3 5: Leading Competitors, Orthopedic Biomaterials Market, China, 2015
  • Chart 4 1: Bone Graft Substitute Procedures by Material, China, 2012 - 2022
  • Chart 4 2: Bone Graft Substitute Procedures by Indication, China, 2012 - 2022
  • Chart 4 3: Total Bone Graft Substitute Units Sold per Procedure by Indication (Excluding Autograft), China, 2012 - 2022
  • Chart 4 4: Hyaluronic Acid Viscosupplementation Procedures by Injection Cycle, China, 2012 - 2022
  • Chart 4 5: Orthopedic Growth Factor Procedures, China, 2012 - 2022
  • Chart 5 1: Bone Graft Substitute Market by Material, China, 2012 - 2022
  • Chart 5 2: Bone Graft Substitute Market Breakdown by Material, China, 2015
  • Chart 5 3: Bone Graft Substitute Market Breakdown by Material, China, 2022
  • Chart 5 4: Bone Graft Substitute Market by Indication, China, 2012 - 2022
  • Chart 5 5: Bone Graft Substitute Market Breakdown by Indication, China, 2015
  • Chart 5 6: Bone Graft Substitute Market Breakdown by Indication, China, 2022
  • Chart 5 7: Total Bone Graft Substitute Market, China, 2012 - 2022
  • Chart 5 8: Allograft Bone Graft Substitute Market, China, 2012 - 2022
  • Chart 5 9: Demineralized Bone Matrix Market, China, 2012 - 2022
  • Chart 5 10: Synthetic Bone Graft Substitute Market, China, 2012 - 2022
  • Chart 5 11: Total Spine Market, China, 2012 - 2022
  • Chart 5 12: Cervical Spine Market, China, 2012 - 2022
  • Chart 5 13: Thoracolumbar Spine Market, China, 2012 - 2022
  • Chart 5 14: Trauma & Reconstruction Market, China, 2012 - 2022
  • Chart 5 15: Bone Tumor Market, China, 2012 - 2022
  • Chart 5 16: Bone Tumor Market, China, 2012 - 2022
  • Chart 5 17: Leading Competitors, Bone Graft Substitute Market, China, 2015
  • Chart 6 1: Hyaluronic Acid Viscosupplementation Market by Injection Cycle, China, 2012 - 2022
  • Chart 6 2: Hyaluronic Acid Viscosupplementation Market Breakdown, China, 2015
  • Chart 6 3: Hyaluronic Acid Viscosupplementation Market Breakdown, China, 2022
  • Chart 6 4: Total Hyaluronic Acid Viscosupplementation Market, China, 2012 - 2022
  • Chart 6 5: Three-Injection Hyaluronic Acid Viscosupplementation Market, China, 2012 - 2022
  • Chart 6 6: Five-Injection Hyaluronic Acid Viscosupplementation Market, China, 2012 - 2022
  • Chart 6 7: Leading Competitors, Hyaluronic Acid Viscosupplementation Market, China, 2015
  • Chart 7 1: Orthopedic Growth Factor Market, China, 2012 - 2022
  • Chart 7 2: Leading Competitors, Orthopedic Growth Factor Market, China, 2015

LIST OF FIGURES

  • Figure 1 1: Orthopedic Biomaterials Market Share Ranking by Segment, China, 2015
  • Figure 1 2: Companies Researched in this Report, China, 2015
  • Figure 1 3: Factors Impacting the Orthopedic Biomaterials Market by Segment, China
  • Figure 1 4: Recent Events in the Orthopedic Biomaterials Market, China, 2012 - 2015
  • Figure 1 5: Orthopedic Biomaterials Procedures Covered, China, 2015
  • Figure 1 6: Orthopedic Biomaterials Markets Covered, China, 2015
  • Figure 1 7: Key Report Updates, China, 2013 & 2016
  • Figure 1 8: Version History
  • Figure 3 1: Currency Exchange Rates, 2015
  • Figure 3 2: Orthopedic Biomaterials Market by Segment, China, 2012 - 2022 (US$M)
  • Figure 3 3: Orthopedic Biomaterials Market by Segment, China, 2012 - 2022 (CN¥M)
  • Figure 3 4: Growth Rates by Segment, Orthopedic Biomaterials Market, China, 2012 - 2022
  • Figure 3 5: Drivers and Limiters, Orthopedic Biomaterials Market, China, 2015
  • Figure 3 6: Leading Competitors, Orthopedic Biomaterials Market, China, 2015
  • Figure 4 1: Bone Graft Substitute Procedures by Material, China, 2012 - 2022
  • Figure 4 2: Bone Graft Substitute Procedures (Excluding Autograft Procedures) by Indication, China, 2012 - 2022
  • Figure 4 3: Total Bone Graft Substitute Units Sold by Indication (Excluding Autograft), China, 2012 - 2022 (10cc)
  • Figure 4 4: Hyaluronic Acid Viscosupplementation Procedures by Injection Cycle, China, 2012 - 2022
  • Figure 4 5: Orthopedic Growth Factor Procedures, China, 2012 - 2022
  • Figure 5 1: Bone Graft Substitute Market by Material, China, 2012 - 2022 (US$M)
  • Figure 5 2: Bone Graft Substitute Market by Material, China, 2012 - 2022 (CN¥M)
  • Figure 5 3: Bone Graft Substitute Market by Indication, China, 2012 - 2022 (US$M)
  • Figure 5 4: Bone Graft Substitute Market by Indication, China, 2012 - 2022 (CN¥M)
  • Figure 5 5: Total Bone Graft Substitute Market, China, 2012 - 2022 (US$ and CN¥)
  • Figure 5 6: Allograft Bone Graft Substitute Market, China, 2012 - 2022 (US$ and CN¥)
  • Figure 5 7: Demineralized Bone Matrix Market, China, 2012 - 2022 (US$ and CN¥)
  • Figure 5 8: Synthetic Bone Graft Substitute Market, China, 2012 - 2022 (US$ and CN¥)
  • Figure 5 9: Total Spine Market, China, 2012 - 2022 (US$ and CN¥)
  • Figure 5 10: Cervical Spine Market, China, 2012 - 2022 (US$ and CN¥)
  • Figure 5 11: Thoracolumbar Spine Market, China, 2012 - 2022 (US$ and CN¥)
  • Figure 5 12: Trauma & Reconstruction Market, China, 2012 - 2022 (US$ and CN¥)
  • Figure 5 13: Bone Tumor Market, China, 2012 - 2022 (US$ and CN¥)
  • Figure 5 14: CMF Market, China, 2012 - 2022 (US$ and CN¥)
  • Figure 5 15: Drivers and Limiters, Bone Graft Substitute Market, China, 2015
  • Figure 5 16: Leading Competitors, Bone Graft Substitute Market, China, 2015
  • Figure 6 1: Hyaluronic Acid Viscosupplementation Market by Injection Cycle, China, 2012 - 2022 (US$M)
  • Figure 6 2: Hyaluronic Acid Viscosupplementation Market by Injection Cycle, China, 2012 - 2022 (CN¥M)
  • Figure 6 3: Total Hyaluronic Acid Viscosupplementation Market, China, 2012 - 2022 (US$ and CN¥)
  • Figure 6 4: Three-Injection Hyaluronic Acid Viscosupplementation Market, China, 2012 - 2022 (US$ and CN¥)
  • Figure 6 5: Five-Injection Hyaluronic Acid Viscosupplementation Market, China, 2012 - 2022 (US$ and CN¥)
  • Figure 6 6: Drivers and Limiters, Hyaluronic Acid Viscosupplementation Market, China, 2015
  • Figure 6 7: Leading Competitors, Hyaluronic Acid Viscosupplementation Market, China, 2015
  • Figure 7 1: Orthopedic Growth Factor Market, China, 2012 - 2022 (US$ and CN¥)
  • Figure 7 2: Drivers and Limiters, Orthopedic Growth Factor Market, China, 2015
  • Figure 7 3: Leading Competitors, Orthopedic Growth Factor Market, China, 2015
目次
Product Code: iDATA_CHOB20_MS

The China orthopedic biomaterials market was valued at $460.7 million in 2019. This is expected to increase over the forecast period at a CAGR of 6% to reach $690.8 million.

Surgical procedures that require the use of orthopedic biomaterials are generally associated with diseases and indications that become more prevalent in the population with an increase in age, such as osteoarthritis of the spine and knee. In 2019, approximately 12% of the Chinese population was aged 65 and over; this proportion is projected to grow steadily over the forecast period, as further cohorts of baby boomers turn 65.

In the past, lower tier hospitals (I and II) were primarily served by local manufacturers with relatively simple products at significantly lower prices than the products purchased by tier III hospitals, which were primarily supplied by international companies. Now, with the financial and regulatory support of the government, increasingly difficult entry barriers for international products and weak intellectual property protection that incentivizes product plagiarism, the market has shifted in favor of local manufacturers.

The full report suite on the Chinese market for orthopedic biomaterials includes bone graft substitutes, which are represented by allografts, demineralized bone matrix (DBM) allografts and synthetics. This report also includes orthopedic growth factors and hyaluronic acid (HA) viscosupplementation.

TABLE OF CONTENTS

TABLE OF CONTENTS

LIST OF FIGURES

LIST OF CHARTS

EXECUTIVE SUMMARY

  • 1.1. CHINESE ORTHOPEDIC BIOMATERIALS MARKET OVERVIEW
  • 1.2. COMPETITIVE ANALYSIS
  • 1.3. MARKET TRENDS
  • 1.4. KEY MARKET DEVELOPMENTS
  • 1.5. PROCEDURE NUMBERS
  • 1.6. MARKETS INCLUDED
  • 1.7. KEY REPORT UPDATES
  • 1.8. VERSION HISTORY

RESEARCH METHODOLOGY

  • 2.1. RESEARCH SCOPE
  • 2.2. IDATA'S 9-STEP METHODOLOGY
  • Step 1: Project Initiation & Team Selection
  • Step 2: Prepare Data Systems and Perform Secondary Research
  • Step 3: Preparation for Interviews & Questionnaire Design
  • Step 4: Performing Primary Research
  • Step 5: Research Analysis: Establishing Baseline Estimates
  • Step 6: Market Forecast and Analysis
  • Step 7: Identify Strategic Opportunities
  • Step 8: Final Review and Market Release
  • Step 9: Customer Feedback and Market Monitoring

CHINESE ORTHOPEDIC BIOMATERIALS MARKET OVERVIEW

  • 3.1. INTRODUCTION
    • 3.1.1. Bone Graft Substitutes
    • 3.1.2. Hyaluronic Acid Viscosupplementation
    • 3.1.3. Growth Factors
  • 3.2. CURRENCY EXCHANGE RATES
  • 3.3. MARKET OVERVIEW
  • 3.4. TREND ANALYSIS
  • 3.5. DRIVERS AND LIMITERS
    • 3.5.1. Market Drivers
    • 3.5.2. Market Limiters
  • 3.6. COMPETITIVE ANALYSIS
  • 3.7. MERGERS AND ACQUISITIONS

PROCEDURE NUMBERS

  • 4.1. BONE GRAFT SUBSTITUTE PROCEDURE NUMBERS
    • 4.1.1. Bone Graft Substitute Procedure Numbers by Material
    • 4.1.2. Bone Graft Substitute Procedure Numbers by Indication
      • 4.1.2.1. Bone Graft Substitute Units per Procedure by Indication
  • 4.2. HYALURONIC ACID VISCOSUPPLEMENTATION PROCEDURE NUMBERS
    • 4.2.1. Hyaluronic Acid Viscosupplementation Procedure Numbers by Injection Cycle
  • 4.3. ORTHOPEDIC GROWTH FACTOR PROCEDURE NUMBERS
    • 4.3.1. Orthopedic Growth Factor Procedure Numbers

BONE GRAFT SUBSTITUTE MARKET

  • 5.1. INTRODUCTION
  • 5.2. MARKET OVERVIEW
    • 5.2.1. Bone Graft Substitute Market by Material
    • 5.2.2. Bone Graft Substitute Market by Indication
  • 5.3. MARKET ANALYSIS AND FORECAST
    • 5.3.1. Total Bone Graft Substitute Market
    • 5.3.2. Total Bone Graft Substitute Market by Material
      • 5.3.2.1. Allograft Bone Graft Substitute Market
      • 5.3.2.2. Demineralized Bone Matrix Market
      • 5.3.2.3. Synthetic Bone Graft Substitute Market
    • 5.3.3. Total Bone Graft Substitute Market by Indication
      • 5.3.3.1. Total Spine Market
      • 5.3.3.1.1. Cervical Spine Market
      • 5.3.3.1.2. Thoracolumbar Spine Market
      • 5.3.3.2. Trauma & Reconstruction Market
      • 5.3.3.3. Bone Tumor Market
      • 5.3.3.4. CMF Market
  • 5.4. DRIVERS AND LIMITERS
    • 5.4.1. Market Drivers
    • 5.4.2. Market Limiters
  • 5.5. COMPETITIVE ANALYSIS

HYALURONIC ACID VISCOSUPPLEMENTATION MARKET

  • 6.1. INTRODUCTION
  • 6.2. MARKET OVERVIEW
    • 6.2.1. Hyaluronic Acid Viscosupplementation Market by Injection Cycle
  • 6.3. MARKET ANALYSIS AND FORECAST
    • 6.3.1. Total Hyaluronic Acid Viscosupplementation Market
    • 6.3.2. Total Hyaluronic Acid Viscosupplementation Market by Injection Cycle
      • 6.3.2.1. Single-Injection Hyaluronic Acid Viscosupplementation Market
      • 6.3.2.2. Three-Injection Hyaluronic Acid Viscosupplementation Market
      • 6.3.2.3. Five-Injection Hyaluronic Acid Viscosupplementation Market
  • 6.4. DRIVERS AND LIMITERS
    • 6.4.1. Market Drivers
    • 6.4.2. Market Limiters
  • 6.5. COMPETITIVE ANALYSIS

ORTHOPEDIC GROWTH FACTOR MARKET

  • 7.1. INTRODUCTION
  • 7.2. MARKET ANALYSIS AND FORECAST
    • 7.2.1. Orthopedic Growth Factor Market
  • 7.3. DRIVERS AND LIMITERS
    • 7.3.1. Market Drivers
    • 7.3.2. Market Limiters
  • 7.4. COMPETITIVE ANALYSIS

APPENDIX: LOCAL COMPETITOR DIRECTORY

  • 8.1. WEBSITE DIRECTORY

ABBREVIATIONS

株式会社グローバルインフォメーション
© Copyright 1996-2021, Global Information, Inc. All rights reserved.